Home Blood Pressure Intervention in the Community Trial
ConditionHome Blood Pressure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-80
SponsorShanghai Institute of Hypertension
About this trial
The primary purpose of the study is to explore whether a lower home blood pressure target (125/75 v.s. 135/85 mmHg) would be beneficial to elderly treated hypertensive patients in terms of reduced incidence of cardiovascular events. The study also aims to promote the application of standardised and information-based home blood pressure monitoring in community hypertension management.
Eligibility criteria
Qualifiers
Aged 60-80 years old
Have been taking antihypertensive drugs for more than 2 weeks
The average SBP and/or DBP of 7-day home blood pressure monitoring ≥135/85 mmHg
Willing to participate, adhere to follow-up, and sign the written informed consent form
Disqualifiers
Arm circumference too large or too small (less than 18 cm or greater than 42 cm) to fit the cuff in case of inaccurate measurement
Invalid home blood pressure monitoring. The valid home blood pressure monitoring requires consecutive measurements for at least 3 days, with not less than 1 measurement in the morning and evening, respectively.
Office blood pressure indicates stage 3 clinic hypertension (≥180/110 mmHg) during the screening period
Suspected or known secondary hypertension
Trial design
Treatments tested in this trial
- Intensive Home BP control
- Standard Home BP control
Treatment groups
10,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov